Dina Leviten

726 total citations
6 papers, 629 citations indexed

About

Dina Leviten is a scholar working on Biochemistry, Physiology and Oncology. According to data from OpenAlex, Dina Leviten has authored 6 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biochemistry, 3 papers in Physiology and 2 papers in Oncology. Recurrent topics in Dina Leviten's work include Sulfur Compounds in Biology (4 papers), Asthma and respiratory diseases (3 papers) and Advanced Chemical Sensor Technologies (2 papers). Dina Leviten is often cited by papers focused on Sulfur Compounds in Biology (4 papers), Asthma and respiratory diseases (3 papers) and Advanced Chemical Sensor Technologies (2 papers). Dina Leviten collaborates with scholars based in Italy and United States. Dina Leviten's co-authors include David Chantry, Carol J. Raport, Silvano Sozzani, Ronald Godiska, Patrick W. Gray, Paola Allavena, Alberto Mantovani, Thomas L. Deckwerth, Åsa Bengtsson and Csaba Szabó and has published in prestigious journals such as The Journal of Experimental Medicine, The FASEB Journal and Annals of Oncology.

In The Last Decade

Dina Leviten

6 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dina Leviten Italy	3	330	220	186	91	89	6	629
Masafumi Shibamori Japan	10	257 0.8×	187 0.8×	17 0.1×	132 1.5×	263 3.0×	15	683
Matthew T. Hardison United States	8	113 0.3×	119 0.5×	24 0.1×	102 1.1×	122 1.4×	9	467
K. Merétey Hungary	9	235 0.7×	48 0.2×	15 0.1×	74 0.8×	121 1.4×	19	450
Mareva Foster United States	11	98 0.3×	104 0.5×	15 0.1×	57 0.6×	154 1.7×	14	571
Sabrina Pagliei Italy	8	137 0.4×	57 0.3×	44 0.2×	42 0.5×	298 3.3×	9	533
J Asai Japan	11	154 0.5×	102 0.5×	11 0.1×	49 0.5×	183 2.1×	26	511
R. A. Lutz United States	11	136 0.4×	115 0.5×	14 0.1×	115 1.3×	318 3.6×	13	684
S. Langbein Germany	15	93 0.3×	101 0.5×	32 0.2×	64 0.7×	448 5.0×	37	925
Jerry L. Hudson United States	12	193 0.6×	115 0.5×	10 0.1×	61 0.7×	191 2.1×	23	561
Suzel Davanture France	10	318 1.0×	196 0.9×	12 0.1×	134 1.5×	226 2.5×	12	643

Countries citing papers authored by Dina Leviten

Since Specialization

Citations

This map shows the geographic impact of Dina Leviten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Leviten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Leviten more than expected).

Fields of papers citing papers by Dina Leviten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Leviten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Leviten. The network helps show where Dina Leviten may publish in the future.

Co-authorship network of co-authors of Dina Leviten

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Leviten. A scholar is included among the top collaborators of Dina Leviten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Leviten. Dina Leviten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Vo, Alex, et al.. (2017). Evaluation of drug-drug interactions (DDI) between tucatinib and capecitabine (C) in patients with advanced HER2+ metastatic breast cancer from a phase 1b study. Annals of Oncology. 28. v98–v98. 1 indexed citations

2.

Wintner, Edward A., Thomas L. Deckwerth, William Langston, et al.. (2010). A monobromobimane‐based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. British Journal of Pharmacology. 160(4). 941–957. 195 indexed citations

3.

Bengtsson, Åsa, Dina Leviten, Michael A. Insko, et al.. (2008). Bioequivalence between inhaled hydrogen sulfide and intravenously administered sodium sulfide. The FASEB Journal. 22(S1). 1 indexed citations

4.

Leviten, Dina, Åsa Bengtsson, Michael A. Insko, et al.. (2008). Distinguishing endogenous and exogenous sulfide by mass spectroscopy. The FASEB Journal. 22(S1). 2 indexed citations

5.

Bengtsson, Åsa, Dina Leviten, Michael A. Insko, et al.. (2008). Use of mono‐bromo‐bimane to derivatize sulfide in whole blood: comparison of blood sulfide levels during atmospheric hydrogen sulfide exposure and intravenous sulfide infusion. The FASEB Journal. 22(S1). 7 indexed citations

6.

Godiska, Ronald, David Chantry, Carol J. Raport, et al.. (1997). Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells. The Journal of Experimental Medicine. 185(9). 1595–1604. 423 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact